Dermapen Side Effects – Micro Needling Side Effects
Do Not Use If You Exhibit Any of the Following:
- History of allergies – Aggressive needling of the abdomen or thigh areas may trigger an allergic reaction, due to the upregulation of histamine production leading to urticaria (hives) that may itch for days.
- Immunosuppression – Do not needle immunosuppressed patients (whether due to disease condition, medication, or other source) due to heightened risk of secondary infection post needling.
- Diabetes – Potential delayed wound healing may increase risk of secondary infection post needling.
- Pustular or nodular rosacea – Do not needle inside zones of inflammation until inflammatory response has dissipated; you can needle nearby, unaffected areas.
- Concurrent use of anticoagulant medication – Anticoagulant medications, such as Coumadin, may contribute to prolonged bleeding. Under no circumstances should medication for a serious health condition be discontinued in favor of aesthetic issues.
- Unnecessarily frequent needling sessions – Needling more than once per month may overstimulate collagenase response, to the detriment of therapeutic goals.
- Injectable neuromodulators – Do not use Dermapen within 48 hours of injection of neuromodulators (such as Botox or Dysport) in proximity to the needled area to avoid potential maldistribution of injected toxins.
- Injectable fillers – Do not use Dermapen within two weeks of injection with dermal fillers or volumizers to avoid potential unwanted inflammatory response.
- Pregnancy – Dry needling without use of topicals or other products is not recommended.
- Presence of palmar or plantar keloid scarring – Use of Dermapen may exacerbate scarring on the palms or soles. When needling clients with keloid scars, antihistamine therapy may inhibit unwanted inflammation.
- Moles, Skin Tags and Various Lesions – Avoid needling moles and other raised lesions with the Dermapen. Investigate and identify any skin irregularities before needling, and evaluate these areas so they can be avoided during a Dermapen needling session. Darkened areas of the skin that look abnormal should also be avoided. Melanoma is a skin cancer that is most commonly found on areas of the body that contain melanocytes. Melanocytes produce melanin, which causes the appearance of a dark “mole” or “freckle”. This skin cancer is especially common in sun-exposed skin and should NEVER be needled with the Dermapen.
Dermapen® Microneedling Devices are exclusively sold to Medical and Skin Care Professionals. Use the form to the right to get started finding a Certified Dermapen® practitioner in your area.
Enter your location information to find a Dermapen Skin Care Professional.
Want to become a Dermapen Practitioner?
Medical Clinics and Spas can offer their patients the worlds most advanced microneedling treatments with Dermapen
The Dermapen Microneedling Pen provides an unparalleled response through the segmented delivery of microneedles, creating micro injuries to the epidermis (outer layer of skin) and dermis (the inner layer of skin). As a result, the micro injuries encourage the body’s innate ability to repair itself.
Every Dermapen tip is outfitted with 12 needles and features our patented technologies, which include SureSpace™ and SafLok™. Accordingly, these safety enhancements can be found in every Dermapen needle tip and pen.
Furthermore, by using SureSpace™ and SafLok™ microneedling pen technologies, practitioners can deliver their patients the safest microneedling treatment possible, while getting the best microneedling results for their patients.